Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TELA Bio, Inc. - Common stock (NQ:TELA)

0.9756 +0.0155 (+1.61%)
Streaming Delayed Price Updated: 4:00 PM EST, Jan 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TELA Bio, Inc. - Common stock

< Previous 1 2 3 4 5 6 Next >
News headline image
TELA Bio: Q4 Earnings Insights ↗
TELA Bio (NASDAQ:TELA) reported its Q4 earnings results on Monday, March 21, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings TELA Bio missed... 
Via Benzinga
News headline image
Earnings Scheduled For March 21, 2022 ↗
Companies Reporting Before The Bell • Marinus Pharmaceuticals (NASDAQ:MRNS) is likely to report quarterly loss at $0.76 per share on revenue of $3.37 million. •... 
Via Benzinga
News headline image
The Week Ahead In Biotech (March 20-26): Focus On Zogenix FDA Decision, Dermatology Conference Presentations & Earnings ↗
Biotech stocks rebounded along with the broader market in the week ending March 18, as risk appetite returned. Multiple conference presentations, clinical readouts and earnings news dictated sentiment... 
Via Benzinga
News headline image
Preview: TELA Bio's Earnings ↗
TELA Bio (NASDAQ:TELA) is set to give its latest quarterly earnings report on Monday, 2022-03-21. Here's what investors need to know before the announcement. Analysts estimate... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
News headline image
ROCE Insights For TELA Bio ↗
In Q1, TELA Bio (NASDAQ:TELA) posted sales of $5.88 million. Earnings were up 7.74%, but TELA Bio still reported an overall loss of $7.27 million. In Q4, TELA Bio brought in $5.67... 
Via Benzinga
News headline image
Insiders Buy Around $98M Of 3 Stocks ↗
Although US stock futures traded lower this morning amid continued Russian bombing in Ukraine, there were a few notable insider trades. W... 
Via Benzinga
News headline image
TELA Bio, Inc. (TELA) Q3 2021 Earnings Call Transcript ↗
TELA earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
TELA Bio, Inc. (TELA) Q2 2021 Earnings Call Transcript ↗
TELA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
TELA Bio: Q2 Earnings Insights ↗
Shares of TELA Bio (NASDAQ:TELA) decreased 2.3% after the company reported Q2 results. Quarterly Results Earnings per share decreased 7.55% over the past year to ($0.57), which... 
Via Benzinga
News headline image
Earnings Outlook For TELA Bio ↗
On Wednesday, August 11, TELA Bio (NASDAQ:TELA) will report its last quarter's earnings. Here is Benzinga's preview of the company's release. Net Income, Earnings, And Earnings... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Gainers RAPT Therapeutics (NASDAQ:RAPT) s... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 11) Adagio Therapeutics, Inc. (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 10) Alnylam Pharmaceuticals,... 
Via Benzinga
News headline image
Earnings Scheduled For August 11, 2021 ↗
Companies Reporting Before The Bell • Wireless Telecom Group (AMEX:WTT) is likely to report earnings for its second quarter. • Gamida Cell (NASDAQ:GMDA) is... 
Via Benzinga
News headline image
TELA Bio Launches Post Market Study Of OviTex In Hernia Surgery ↗
TELA Bio Inc (NASDAQ: TELA) has launched its second post-market study, BRAVO II, to evaluate the clinical performance of OviTex Reinforced Tissue Matrices in the... 
Via Benzinga
News headline image
TELA Bio, Inc. (TELA) Q1 2021 Earnings Call Transcript ↗
TELA earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
TELA Bio: Q1 Earnings Insights ↗
Shares of TELA Bio (NASDAQ:TELA) rose in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 11.11% year over year to ($0.56... 
Via Benzinga
News headline image
TELA Bio Inc. (TELA) Q4 2020 Earnings Call Transcript ↗
TELA earnings call for the period ending December 31, 2020. 
Via The Motley Fool
Topics Earnings
News headline image
Earnings Scheduled For May 13, 2021 ↗
Companies Reporting Before The Bell • CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million. •... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.